@inproceedings{inproceedings, title  = {{A phase 2 randomized, double-blind, placebo-controlled trial of radium-223 dichloride with exemestane and everolimus in patients with HER2–negative hormone receptor–positive breast cancer and bone metastases}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2016}},

 month = {{10}},

 author = {{Rugo H and Petrenciuc O and Zhang A and Li R and Coleman RE}},

 doi = {{10.1093/annonc/mdw365.89}},

 volume = {{27}},

 journal = {{Annals of Oncology}},

 pages = {{vi97-vi97}},

 note = {{Accessed on 2025/10/10}}}